Literature DB >> 23194472

Pseudomonas aeruginosa lipopolysaccharide inhibits Candida albicans hyphae formation and alters gene expression during biofilm development.

H M H N Bandara1, B P K Cheung, R M Watt, L J Jin, L P Samaranayake.   

Abstract

Elucidation of bacterial and fungal interactions in multispecies biofilms will have major impacts on understanding the pathophysiology of infections. The objectives of this study were to (i) evaluate the effect of Pseudomonas aeruginosa lipopolysaccharide (LPS) on Candida albicans hyphal development and transcriptional regulation, (ii) investigate protein expression during biofilm formation, and (iii) propose likely molecular mechanisms for these interactions. The effect of LPS on C. albicans biofilms was assessed by XTT-reduction and growth curve assays, light microscopy, scanning electron microscopy (SEM), and confocal laser scanning microscopy (CLSM). Changes in candidal hypha-specific genes (HSGs) and transcription factor EFG1 expression were assessed by real-time polymerase chain reaction and two-dimensional gel electrophoresis, respectively. Proteome changes were examined by mass spectrometry. Both metabolic activities and growth rates of LPS-treated C. albicans biofilms were significantly lower (P < 0.05). There were higher proportions of budding yeasts in test biofilms compared with the controls. SEM and CLSM further confirmed these data. Significantly upregulated HSGs (at 48 h) and EFG1 (up to 48 h) were noted in the test biofilms (P < 0.05) but cAMP levels remained unaffected. Proteomic analysis showed suppression of candidal septicolysin-like protein, potential reductase-flavodoxin fragment, serine hydroxymethyltransferase, hypothetical proteins Cao19.10301(ATP7), CaO19.4716(GDH1), CaO19.11135(PGK1), CaO19.9877(HNT1) by P. aeruginosa LPS. Our data imply that bacterial LPS inhibit C. albicans biofilm formation and hyphal development. The P. aeruginosa LPS likely target glycolysis-associated mechanisms during candidal filamentation.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23194472     DOI: 10.1111/omi.12006

Source DB:  PubMed          Journal:  Mol Oral Microbiol        ISSN: 2041-1006            Impact factor:   3.563


  20 in total

1.  Cross-feeding and interkingdom communication in dual-species biofilms of Streptococcus mutans and Candida albicans.

Authors:  Helena Sztajer; Szymon P Szafranski; Jürgen Tomasch; Michael Reck; Manfred Nimtz; Manfred Rohde; Irene Wagner-Döbler
Journal:  ISME J       Date:  2014-05-13       Impact factor: 10.302

Review 2.  [Research progress on interactions between Candida albicans and common oral pathogens].

Authors:  Ling Deng; Jing Xue; Li Jiang; Ling Zou; Wei Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2019-12-01

3.  Studies of Pseudomonas aeruginosa Mutants Indicate Pyoverdine as the Central Factor in Inhibition of Aspergillus fumigatus Biofilm.

Authors:  Gabriele Sass; Hasan Nazik; John Penner; Hemi Shah; Shajia Rahman Ansari; Karl V Clemons; Marie-Christine Groleau; Anna-Maria Dietl; Paolo Visca; Hubertus Haas; Eric Déziel; David A Stevens
Journal:  J Bacteriol       Date:  2017-12-05       Impact factor: 3.490

Review 4.  Sensing of the microbial neighborhood by Candida albicans.

Authors:  Emily M Mallick; Richard J Bennett
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

5.  Inhibition of biofilm formation and lipase in Candida albicans by culture filtrate of Staphylococcus epidermidis in vitro.

Authors:  Sayan Bhattacharyya; Prashant Gupta; Gopa Banerjee; Amita Jain; Mastan Singh
Journal:  Int J Appl Basic Med Res       Date:  2014-09

Review 6.  Anti-Immune Strategies of Pathogenic Fungi.

Authors:  Caroline M Marcos; Haroldo C de Oliveira; Wanessa de Cássia M Antunes de Melo; Julhiany de Fátima da Silva; Patrícia A Assato; Liliana Scorzoni; Suélen A Rossi; Ana C A de Paula E Silva; Maria J S Mendes-Giannini; Ana M Fusco-Almeida
Journal:  Front Cell Infect Microbiol       Date:  2016-11-15       Impact factor: 5.293

7.  Polymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans-Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy.

Authors:  Maria E Rodrigues; Susana P Lopes; Cláudia R Pereira; Nuno F Azevedo; Anália Lourenço; Mariana Henriques; Maria O Pereira
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

Review 8.  Iron at the Centre of Candida albicans Interactions.

Authors:  Ruan Fourie; Oluwasegun O Kuloyo; Bonang M Mochochoko; Jacobus Albertyn; Carolina H Pohl
Journal:  Front Cell Infect Microbiol       Date:  2018-06-05       Impact factor: 5.293

9.  Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa Is Dependent on the Source, Phenotype and Growth Conditions of the Bacterium.

Authors:  Jose A G Ferreira; John C Penner; Richard B Moss; Janus A J Haagensen; Karl V Clemons; Alfred M Spormann; Hasan Nazik; Kevin Cohen; Niaz Banaei; Elisabete Carolino; David A Stevens
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

Review 10.  Candida albicans and Pseudomonas aeruginosa Interaction, with Focus on the Role of Eicosanoids.

Authors:  Ruan Fourie; Ruan Ells; Chantel W Swart; Olihile M Sebolai; Jacobus Albertyn; Carolina H Pohl
Journal:  Front Physiol       Date:  2016-02-26       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.